HIGHLIGHTS
- who: Alina Zubarevich from the Between April , and June, consecutive patients underwent a SU-AVR for various indications at our institutionOf those, patients underwent a SUAVR due to pure severe aortic regurgitation. We analyzed the outcomes and postoperative complications in patients undergoing SU-SAVR using Perceval (Corcym) due to pure severe aortic regurgitation. Patients presenting with infective endocarditis and those in whom a concomitant valve procedure was required have been excluded from the study. Data were obtained from the institutional database that includes detailed information on patients' demographics, baseline clinical characteristics, and their laboratory and hemodynamic parameters . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.